ORIENT BIO Inc. (KRX:002630)
South Korea · Delayed Price · Currency is KRW 562.00
+17.00 (3.12%)
At close: Nov 26, 2025
ORIENT BIO Market Cap
ORIENT BIO has a market cap or net worth of 66.64 billion as of November 26, 2025. Its market cap has increased by 24.06% in one year.
Market Cap
66.64B
Enterprise Value
n/a
Revenue
59.09B
Ranking
n/a
PE Ratio
n/a
Stock Price
562.00
Market Cap Chart
Since August 30, 1995, ORIENT BIO's market cap has increased from 31.20B to 66.64B, an increase of 113.57%. That is a compound annual growth rate of 2.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 66.64B | -63.67% |
| Dec 30, 2024 | 183.42B | 154.86% |
| Dec 28, 2023 | 71.97B | -0.98% |
| Dec 29, 2022 | 72.68B | -49.75% |
| Dec 30, 2021 | 144.65B | -3.55% |
| Dec 30, 2020 | 149.97B | 116.58% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.00T |
| ALTEOGEN | 28.93T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.86T |
| Yuhan | 8.73T |
| Peptron | 8.60T |
| LigaChem Biosciences | 6.49T |